Maravai LifeSciences Holdings, Inc. (MRVI) vs Vericel Corporation (VCEL)
Maravai LifeSciences Holdings, Inc. and Vericel Corporation are both Biotechnology companies. Maravai LifeSciences Holdings, Inc. and Vericel Corporation are of similar size ($2.0B and $2.0B). Maravai LifeSciences Holdings, Inc. has negative trailing earnings, so its P/E is not meaningful; Vericel Corporation trades at 82.6×. Vericel Corporation grew revenue faster over the last twelve months: 23.0% against −5.03%. Vericel Corporation has the higher net margin (7.91% vs −37.1%) and the higher return on invested capital (5.49% vs −15.8%). Across the 19 metrics below, Vericel Corporation leads on 16 and Maravai LifeSciences Holdings, Inc. on 3.
Valuation
Profitability
| Metric | MRVI | VCEL | Biotechnology median |
|---|---|---|---|
| Gross margin | 34.89% | 74.56% | 65.16% |
| Operating margin | (56.08%) | 5.95% | 0.00% |
| Net margin | (37.07%) | 7.91% | 0.00% |
| Free cash flow margin | (17.17%) | 20.13% | 0.00% |
| Return on equity | (18.79%) | 7.16% | (57.72%) |
| Return on assets | (10.31%) | 5.16% | (49.22%) |
| Return on invested capital | (15.83%) | 5.49% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack